40 related articles for article (PubMed ID: 22323340)
1. Antiganglioside antibody frequency in routine clinical care settings.
Giesche N; Böhm-Gonzalez ST; Kleiser B; Kowarik MC; Dubois E; Stransky E; Armbruster M; Grimm A; Marquetand J
Eur J Neurol; 2024 Jul; 31(7):e16290. PubMed ID: 38556758
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal immunoglobulin production in patients with systemic lupus erythematosus with neuropsychiatric manifestations.
Mok MY; Chan EY; Wong WS; Lau CS
Ann Rheum Dis; 2007 Jun; 66(6):846-7. PubMed ID: 17513577
[No Abstract] [Full Text] [Related]
3. Neurological Complications in Patients with Systemic Lupus Erythematosus.
Shaban A; Leira EC
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):97. PubMed ID: 31773306
[TBL] [Abstract][Full Text] [Related]
4. Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus.
Wang M; Wang Z; Zhang S; Wu Y; Zhang L; Zhao J; Wang Q; Tian X; Li M; Zeng X
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078885
[TBL] [Abstract][Full Text] [Related]
5. An Atypical Case of Miller Fisher Syndrome with Multiple Autoimmunity.
Mercado C; Perez-Rueda M
Neuroophthalmology; 2022; 46(2):122-125. PubMed ID: 35273417
[TBL] [Abstract][Full Text] [Related]
6. Sialoglyco-Conjugate Abnormalities, IL-6 Trans-Signaling and Anti-Ganglioside Immune Response-Potential Interferences in Lupus Nephritis Pathogenesis.
Ene CD; Penescu MN; Nicolae I
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34205600
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides in Podocyte Biology and Disease.
Savas B; Astarita G; Aureli M; Sahali D; Ollero M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348903
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
Harden OC; Hammad SM
Front Immunol; 2020; 11():586737. PubMed ID: 33101319
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
Hanly JG; Li Q; Su L; Urowitz MB; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Steinsson K; Ramsey-Goldman R; Zoma AA; Manzi S; Nived O; Jonsen A; Khamashta MA; Alarcón GS; Svenungsson E; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Ramos-Casals M; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Theriault C; Farewell V
Arthritis Rheumatol; 2020 Jan; 72(1):67-77. PubMed ID: 31390162
[TBL] [Abstract][Full Text] [Related]
10. The association between autoantibodies and peripheral neuropathy in lupus nephritis.
Su YJ; Huang CR; Chang WN; Tsai NW; Kung CT; Lin WC; Huang CC; Su CM; Cheng BC; Chang YT; Lu CH
Biomed Res Int; 2014; 2014():524940. PubMed ID: 24864250
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.
Stock AD; Wen J; Putterman C
Front Immunol; 2013 Dec; 4():484. PubMed ID: 24400009
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
13. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus.
Perricone C; Pendolino M; Olivieri M; Conti F; Valesini G; Alessandri C
Isr Med Assoc J; 2015 Mar; 17(3):171-8. PubMed ID: 25946769
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
Kusunoki S; Kaida K
J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
[TBL] [Abstract][Full Text] [Related]
16. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.
Labrador-Horrillo M; Martinez-Valle F; Gallardo E; Rojas-Garcia R; Ordi-Ros J; Vilardell M
Lupus; 2012 May; 21(6):611-5. PubMed ID: 22323340
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
